A cream and an injection need different answers
GHK-Cu is a small peptide, a short chain of protein building blocks, joined to copper. In skincare, its ingredient name is also Copper Tripeptide-1. You may recognise the name from a cream before ever seeing a research paper.
The useful question is what researchers tested. Putting something on skin and injecting it are different ways of using it. Evidence about a cream can't tell us that an injection helps someone recover.
What the skin reports say
A review of GHK-Cu skin research describes small human studies of creams. It reports improvements in skin appearance, including fine lines. That's a reason to look more closely, with the word small kept in view.
There's another catch: several reports behind that review were meeting reports or other accounts outside full journal papers. We're reading the review's summary of them. That leaves less detail to judge how reliable or widely useful the findings are.
Skin is a barrier, by design
A later review of topical GHK points to limited clinical research and problems getting the ingredient through skin. Topical simply means applied to the skin. The cream or gel carrying it is part of the experiment.
A lab study of pieces of human skin measured copper passing into and through the samples after GHK-Cu was applied. It measured copper, not intact peptide moving through a living person.
That difference matters when a claim jumps from skin penetration to whole-body repair. The experiment couldn't tell us how anyone's joints felt or whether their day was easier.
Safety depends on the same details
Small skin studies can't settle uncommon or long-term harms. They also can't establish the safety of injection. FDA's concerns about injectable GHK-Cu include possible immune reactions linked to clumping and peptide impurities, with little human safety information.
On that FDA page, current as of April 22, 2026, the injectable nomination is listed as withdrawn. That isn't clearance or permission to compound. The entry is specifically about injection; it doesn't describe every cosmetic or non-injected use.
I keep coming back to the preparation and the question it was tested for. The KPV vs GHK Cu comparison shows why that matters when two names end up under the same recovery heading. They don't arrive with the same evidence.